Tempest Therapeutics (NASDAQ:TPST) Explodes 2,100% Higher on New Data Release –
- Tempest Therapeutics (NASDAQ:TPST) Explodes 2,100% Higher on New Data Release – TipRanks.com TipRanks
- Tempest Therapeutics’ stock jumps nearly 4000% as liver-cancer treatment shows promise MarketWatch
- Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study Yahoo Finance
- Tempest Therapeutics stock soars 4000% on updated data (NASDAQ:TPST) Seeking Alpha
- First-Line TPST-1120 Plus Atezolizumab/Bevacizumab Improves Responses in Unresectable or Metastatic HCC OncLive
- View Full Coverage on Google News
Read More: Tempest Therapeutics (NASDAQ:TPST) Explodes 2,100% Higher on New Data Release –